Citation Impact
Citing Papers
Risk Factors for Venous Thromboembolism
2003 Standout
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014
2015 Standout
Incidence of Venous Thromboembolism in Patients Hospitalized with Cancer
2006
Hypoxia-inducible factors and RAB22A mediate formation of microvesicles that stimulate breast cancer invasion and metastasis
2014 StandoutNobel
Double-blind randomised trial of very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer
1994
Thromboprophylaxis in the Cancer Patient
2001
The risk of venous thromboembolism is increased throughout the course of malignant glioma
2000
Thromboembolic complications after perioperative chemotherapy in women with early breast cancer: a European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group study.
1994
Pancreatic cancer
2004 Standout
IL‐1 and IL‐6 release by tumor‐associated macrophages from human ovarian carcinoma
1989
Mechanisms of Thrombus Formation
2008 Standout
Physical Principles of Membrane Shape Regulation by the Glycocalyx
2019 StandoutNobel
Tissue factor apoprotein: Intracellular transport and expression in shed membrane vesicles
1987
Particulate air pollution and acute health effects
1995 Standout
Trousseau's syndrome in association with ovarian carcinoma
1996
Prognosis of Cancers Associated with Venous Thromboembolism
2000 Standout
Randomized trial of chemotherapy and radiation therapy with or without warfarin for limited-stage small-cell lung cancer: a Cancer and Leukemia Group B study.
1997
Paraneoplastic Syndromes Involving the Nervous System
2003 Standout
Evidence‐based risk factors for postoperative deep vein thrombosis
2004
Validation of Clinical Classification Schemes for Predicting Stroke
2001 Standout
Malignancies, Prothrombotic Mutations, and the Risk of Venous Thrombosis
2005 Standout
Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome
2005 Standout
The Management of Thrombosis in the Antiphospholipid-Antibody Syndrome
1995 Standout
Immunohistochemical identification of tissue factor in solid tumors
1992
Heat Shock Protein A12B Protects Vascular Endothelial Cells Against Sepsis-Induced Acute Lung Injury in Mice
2017 Standout
Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study
2008 Standout
Evidence that nitric oxide is an endogenous antiangiogenic mediator
1994
Antithrombotic Therapy for VTE Disease
2012 Standout
Incidence of Chronic Thromboembolic Pulmonary Hypertension after Pulmonary Embolism
2004 Standout
A Prospective Study of Venous Thromboembolism after Major Trauma
1994 Standout
HIF-1α Is Essential for Myeloid Cell-Mediated Inflammation
2003 Standout
Duration of Prophylaxis against Venous Thromboembolism with Enoxaparin after Surgery for Cancer
2002 Standout
Prevention of Venous Thromboembolism
2004 Standout
Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer
2003 Standout
Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells
1996 Standout
Human polymorphonuclear leukocytes produce and express functional tissue factor upon stimulation
2006
Hemostatic alterations in cancer patients
1992
Primary prevention of arterial thromboembolism in non-rheumatic atrial fibrillation in primary care: randomised controlled trial comparing two intensities of coumarin with aspirin
1999
Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial
2007 Standout
Nitric oxide synthase modulates angiogenesis in response to tissue ischemia.
1998 Standout
Mechanisms of Hypercoagulation in Malignancy and during Chemotherapy
1998
Thrombosis Prophylaxis in Patient Populations With a Central Venous Catheter
2003
Complete sequence of the human tissue factor gene, a highly regulated cellular receptor that initiates the coagulation protease cascade
1989
Primary brain tumours in adults
2012 Standout
Low-Molecular-Weight Heparin in Patients With Advanced Cancer: A Phase 3 Clinical Trial
2006
Disseminated Intravascular Coagulation
1999 Standout
Evaluation of perioperative fatal pulmonary embolism and death in cancer surgical patients
2005
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
1992 Standout
Risk factors for chemotherapy‐associated venous thromboembolism in a prospective observational study
2005
Guidelines for the Prevention of Intravascular Catheter-related Infections
2011 Standout
A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients
1999 Standout
Pancreatic cancer and thromboembolic disease
2004
Chemotherapy-induced thrombosis
2006
Rates of Initial and Recurrent Thromboembolic Disease Among Patients with Malignancy Versus Those without Malignancy: Risk Analysis Using Medicare Claims Data
1999
The Thrombogenic Effect of Anticancer Drug Therapy in Women with Stage II Breast Cancer
1988
Prevention of Venous Thromboembolism
1998
Thromboembolism in brain tumors
2001
Venous thromboembolism and survival in patients with high-grade glioma
2007
Pancreatic cancer
2011 Standout
The Tumor Necrosis Factor Ligand and Receptor Families
1996 StandoutNobel
Cancer of the Ovary
2004 Standout
Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro.
1987
Extracellular vesicles: Exosomes, microvesicles, and friends
2013 Standout
Modulation of endothelial cell hemostatic properties by tumor necrosis factor.
1986 Standout
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
2017 Standout
Macroalgal blooms in shallow estuaries: Controls and ecophysiological and ecosystem consequences
1997 Standout
Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis
2002 Standout
Tumor hypoxia, the physiological link between Trousseau's syndrome (carcinoma-induced coagulopathy) and metastasis.
2001
Microvesicles: mediators of extracellular communication during cancer progression
2010
Monocyte procoagulant activity in Whipple's disease
1984
Atherosclerosis: Basic Mechanisms
1995 Standout
Fibrin as a component of the tumor stroma: origins and biological significance
1983
Prevention of Venous Thromboembolism
1992
Accelerating loss of seagrasses across the globe threatens coastal ecosystems
2009 Standout
Trousseau's syndrome: multiple definitions and multiple mechanisms
2007
Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells.
1984
Trousseau's syndrome.
1993
Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation
2007 Standout
Cytokines and hemostasis.
2000
The Hypercoagulable States
1985
Structural design and molecular evolution of a cytokine receptor superfamily.
1990 Standout
Somatic inactivation of the PHD2 prolyl hydroxylase causes polycythemia and congestive heart failure
2007 StandoutNobel
The Epidemiology of Venous Thromboembolism
2003 Standout
Quantification of risk factors for venous thromboembolism: a preliminary study for the development of a risk assessment tool.
2003
COAGULATION DISORDERS IN CANCER
1996
Low-molecular-weight heparin in the management of Tyrousseau's syndrome
1997
Low-Molecular-Weight Heparins
1997 Standout
Disseminated intravascular coagulation due to malignancy.
1990
Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis.
1989 Standout
Secretory products of macrophages.
1987 Standout
Prevention of Venous Thromboembolism
1995
Regulation of Extravascular Coagulation by Microvascular Permeability
1985 Science
Endothelial cells in physiology and in the pathophysiology of vascular disorders.
1998 Standout
Paradoxical Vasoconstriction Induced by Acetylcholine in Atherosclerotic Coronary Arteries
1986 Standout
Tumors: Wounds That Do Not Heal
1986 Standout
Binding of human factor VII and VIIa to monocytes.
1982
Human alveolar macrophages synthesize factor VII in vitro. Possible role in interstitial lung disease.
1985
Works of RL Edwards being referenced
Mononuclear cell tissue factor: cell of origin and requirements for activation
1979
The effect of serum on monocyte tissue factor generation
1984
Activation of blood coagulation in cancer: Trousseau's syndrome revisited
1983
Mononuclear cell tissue factor: cell of origin and requirements for activation
1979
Assessment of macroalgal nitrogen limitation in a seasonal upwelling region
1989
Activation of blood coagulation in cancer: Trousseau's syndrome revisited
1983